| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/23/2006 | WO2005123761A8 GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION |
| 02/23/2006 | WO2005031758A3 Method for producing carrier-free 72as, device for automatically producing carrier-free 72as, carrier-free 72as(iii) halide, and use thereof |
| 02/23/2006 | WO2003070889A3 Prostate specific genes and the use thereof in design or therapeutics |
| 02/23/2006 | US20060041105 Peptides whose uptake by cells is controllable |
| 02/23/2006 | US20060040964 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 02/23/2006 | US20060040959 Adenosine A3 receptor modulators |
| 02/23/2006 | US20060040324 Methods for making metallopeptides and metallopeptide libraries |
| 02/23/2006 | US20060039861 For magnetic resonance imaging (MRI); peptide modified at its N- and its C-termini, independently, with a moiety comprising a metal chelate complex; specific binding affinity for fibrin; sufficient half-life in vivo |
| 02/23/2006 | US20060039860 Delivering a biopolymer to a cell by forming a complex of a biologically active polymer and a cyclic amidinium-containing compound and associating the complex with the cell |
| 02/23/2006 | US20060039859 using three functional constituents e.g. an amyloid targeted-peptide sequence; a linker moiety; and a peptide-based chelation core(e.g. diethylenetriaminepentaacetic acid DTPA, EDTA) for incorporation of technetium-99m for medical imaging; conjugate binds to amyloid plaques associataed with Alzheimer |
| 02/23/2006 | US20060039858 Radiolabeled antibodies and peptides for treatment of tumors |
| 02/23/2006 | US20060039857 Tumor necrosis factor receptor 1 specific immunoglobulins for targeted immaging and treatment and diagnosis of cell proliferative and autoimmune disorders |
| 02/23/2006 | US20060039856 Magnetic resonance with stimulation |
| 02/23/2006 | US20060039855 Treatment of a solid support-bound precursor of formula:SOLID SUPPORT-LINKER-SO2 O-TRACER with 18F- to produce the labelled tracer, removal of excess 18F-, for example by ion-exchange chromatography; and/or removal of any protecting groups; and/orremoval of organic solvent |
| 02/23/2006 | DE102004062568B3 New radioactive metal chelate, complexes useful for nuclear medicine diagnosis and internal radionuclide therapy |
| 02/23/2006 | CA2573819A1 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease |
| 02/22/2006 | CN1738815A 整联蛋白靶向的影像剂 Integrin targeting imaging agent |
| 02/22/2006 | CN1738652A Improved linkers for pharmaceutical compounds |
| 02/22/2006 | CN1738650A 改进的胃泌素释放肽化合物 Improved gastrin-releasing peptide compounds |
| 02/22/2006 | CN1738645A Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 02/22/2006 | CN1737011A Lymphoma specific chimeric monoclonal antibody against HLA-DR10 |
| 02/21/2006 | US7001888 Compositions and methods for treating cancer |
| 02/21/2006 | US7001616 Microspheres for use in the treatment of cancer |
| 02/16/2006 | WO2006017619A2 Receptor-binding cyclic peptides and methods of use |
| 02/16/2006 | WO2006017333A2 Shortened carbon nanotubes |
| 02/16/2006 | WO2005079391A3 Contrast agents for myocardial perfusion imaging |
| 02/16/2006 | WO2005013897A3 Magnetic nanoparticle compositions, and methods related thereto |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | US20060034773 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 02/16/2006 | US20060034772 Composition comprising low density microspheres |
| 02/16/2006 | US20060034760 Radiopharmaceutical formulations |
| 02/16/2006 | US20060034759 Production and use of novel peptide-based agents with bispecific antibodies |
| 02/16/2006 | US20060034758 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 02/16/2006 | DE19807727B4 Radioaktiver Ballon für ein Ballon-Dilatations-Kathetersystem und Verfahren zu dessen Herstellung Radioactive balloon for a balloon dilatation catheter system and method for its preparation |
| 02/16/2006 | DE102004036882A1 Bioresorbierbares Material zur Füllung von Knochendefekten Bioresorbable material for filling bone defects |
| 02/16/2006 | DE102004036881A1 Bioresorbierbares Material zur Füllung von Knochendefekten Bioresorbable material for filling bone defects |
| 02/16/2006 | CA2575756A1 Combination therapy using transferrin fusion proteins comprising glp-1 |
| 02/15/2006 | EP1624902A1 Methods of producing carbon-13 labeled biomass |
| 02/15/2006 | EP1624901A2 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals |
| 02/15/2006 | EP1624900A2 Methods for binding agents to beta-amyloid plaques |
| 02/15/2006 | EP0836651B1 Electrochemiluminescent monitoring of compounds |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/14/2006 | US6998107 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography |
| 02/14/2006 | US6998106 Radioconjugation of internalizing antibodies |
| 02/14/2006 | US6998105 Low density radionuclide-containing particulate material |
| 02/14/2006 | US6997923 Method and apparatus for EMR treatment |
| 02/09/2006 | WO2006014646A2 Methods for diagnosis using anti-cytokine receptor antibodies |
| 02/09/2006 | WO2006014589A2 Virtual colonoscopy with radiolabeled phospholipid ether analogs |
| 02/09/2006 | WO2006014381A2 Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies |
| 02/09/2006 | WO2003040693A3 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | WO2001070095A3 Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 02/09/2006 | US20060029545 Metal radionuclide complexed directly to a an annexin that has been modified to add a sulfhydryl group which participates in the complexation of the metal radionuclide; useful for imaging vascular thrombi |
| 02/09/2006 | US20060029544 Receptor-binding cyclic peptides and methods of use |
| 02/09/2006 | US20060029543 Treatment of B-cell lymphoma |
| 02/09/2006 | CA2830939A1 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 02/09/2006 | CA2587253A1 A method of diagnosing prodromal forms of diseases associated with amyloid deposition |
| 02/09/2006 | CA2572398A1 Virtual colonoscopy with radiolabeled phospholipid ether analogs |
| 02/09/2006 | CA2515495A1 Methods for preparing metal-carborane complexes for radioimaging and radiotherapy |
| 02/09/2006 | CA2477020A1 Methods for preparing metal-carborane complexes for radioimaging and radiotherapy |
| 02/08/2006 | EP1622650A2 Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy |
| 02/08/2006 | EP1622646A2 Treatment of lupus targeting the macrophages or the folate receptor |
| 02/08/2006 | EP1622602A2 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 02/08/2006 | EP1109795B1 Thiazoline acid derivatives |
| 02/08/2006 | EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/08/2006 | EP0812356B1 Prostate-specific membrane antigen and uses thereof |
| 02/07/2006 | US6995260 Carboranylporphyrins and uses thereof |
| 02/07/2006 | US6995135 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 02/07/2006 | US6994840 Kit for radiolabeling ligands with yttrium-90 |
| 02/02/2006 | WO2006012616A2 Therapeutic use of anti-tf-antigen antibody |
| 02/02/2006 | WO2006012355A2 Radiolabeled nanohybrids targeting solid tumor neovasculature and method of using same |
| 02/02/2006 | WO2006012264A1 Compounds of the inventions of guanylyl cyclase c |
| 02/02/2006 | WO2005004809A3 Multivalent carriers of bi-specific antibodies |
| 02/02/2006 | US20060024235 Stabilised superparamagnetic particles |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | US20060024232 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface |
| 02/02/2006 | US20060024231 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface |
| 02/02/2006 | US20060024230 Customized therapeutics and in situ diagnostics |
| 02/02/2006 | US20060024229 Method and product for locating an internal bleeding site |
| 02/02/2006 | CA2572226A1 Radiolabeled nanohybrids targeting solid tumor neovasculature and method of using same |
| 02/01/2006 | EP1621626A1 AAV Vectors for the manufacture of medicaments for convection enhanced delivery |
| 02/01/2006 | EP1621625A2 AAV vectors for the manufacture of medicaments for convention enhanced delivery |
| 02/01/2006 | EP1621622A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 02/01/2006 | EP1620373A2 Device and method for the fluorination of nucleophiles |
| 02/01/2006 | EP1620135A1 In vivo imaging using peptide derivatives |
| 02/01/2006 | EP1620134A1 Microwave method for preparing radiolabelled gallium complexes |
| 02/01/2006 | EP0956040B1 Stimulation of host defense mechanisms against viral challenges |
| 02/01/2006 | EP0898478B1 Stimulation of host defence mechanisms against tumors |
| 02/01/2006 | CN1729197A Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 02/01/2006 | CN1729180A Piperazinyl and diazapanyl benzamides and benzthioamides |
| 02/01/2006 | CN1239131C Method and apparatus for therapeutic EMR treatment of the skin |
| 01/31/2006 | US6991776 Halogenated xanthene or halogenated xanthene derivative; cancer treatment |
| 01/31/2006 | US6991775 Peptide-based multimeric targeted contrast agents |
| 01/27/2006 | CA2475762A1 Dose dependent elimination of ha and cell receptor stimulation |
| 01/26/2006 | WO2006008496A2 Improved n4 chelator conjugates |
| 01/26/2006 | WO2005102396A3 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 01/26/2006 | WO2005079868A3 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses |
| 01/26/2006 | WO2005077343A3 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 01/26/2006 | WO2005072780A3 Cellular labeling for nuclear magnetic resonance techniques |
| 01/26/2006 | US20060020117 Partial extraction of the antithrombin during the fractionation of human plasma so that the final albumin has an active antithrombin content equal to or greater than 0.03 mg/g of albumin |